Recursion Pharmaceuticals Inc - Ordinary Shares - Class A


Market Cap$2.78B

Compare Recursion Pharmaceuticals- Ordinary Shares

P/E RatioDividendsReturn on EquityPrice-to-SalesDebt-to-Equity
Recursion Pharmaceuticals Inc - Ordinary Shares - Class ARecursion Pharmaceuticals Inc - Ordinary Shares - Class A-9.50%-67%-0.1
marketMarket Avg49.61.28%30%6.11.1
HealthcareHealthcare Avg32.71.25%19%7.40.9

Share Statistics

Market cap$2.78 Billion
Enterprise Value$2.45 Billion
Dividend Yield$0.0 (0.0%)
Earnings per Share$-1.48
Outstanding Shares208,283,925
Avg 30 Day Volume7,157,667


Return on Equity-
Return on Assets-
Return on Invested Capital-

Valuation & Multiples

P/E Ratio-9.52
Price to Sales-
Price to Book Ratio6.73
Enterprise Value to Revenue51.71
Enterprise Value to EBIT-7.85
Enterprise Value to Net Income-9
Total Debt to Enterprise0.02
Debt to Equity0.12

Revenue Sources

No data

ESG Score

No data

About Recursion Pharmaceuticals Inc

218 employees

Recursion is a clinical-stage biotechnology company decoding biology by integrating technological innovations across biology, chemistry, automation, data science, and engineering, with the goal of radically improving the lives of patient...